NURIX THERAPEUTICS INC (NRIX)

US67080M1036 - Common Stock

16.59  +1.19 (+7.73%)

After market: 16.59 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-2-29)
2023
(2023-11-30)
2022
(2022-11-30)
2021
(2021-11-30)
2020
(2020-11-30)
Revenue
80.89M76.99M38.63M29.75M17.82M
Operating Expenses
238.22M232.05M222.49M147.64M82.80M
Research and Development
193.34M189.15M184.50M116.43M66.49M
Selling, General, and Administrative Expenses
44.88M42.90M38.00M31.20M16.31M
Operating Income
-157.33M-155.06M-183.87M-117.89M-64.98M
Interest Income/Expense
12.69M11.12M3.51M820.00K1.21M
Income Before Taxes
-144.64M-143.95M-180.36M-117.06M-63.78M
Income Tax
N/AN/A0.00130.00K-20.54M
Net Income
-144.73M-143.95M-180.36M-117.19M-43.24M
EBITDA
-149.50M-147.53M-178.52M-115.10M-62.80M
 
Per Share Data
EPS Diluted Total Ops
-2.65-2.65-3.71-2.73-1.11
Non GAAP EPS
-2.66-2.65-3.73-2.73N/A
 
Statistics
Profit Margin
-178.92%-186.98%-466.89%-393.92%-242.65%
Operating Profit Margin
-194.49%-201.41%-475.98%-396.27%-364.65%

All data in USD

Charts